We discuss the association of obesity with sarcopenia (a form of SM atrophy), the metabolic sequelae of sarcopenia (including the key role of the SM in determining insulin sensitivity), and the inherent difficulties of clinical assessment of SM mass and functioning in the context of obesity. This evidence concerns the gene INS and sarcopenia.